Director, Specialty & Emerging Pharmacy Channels

Director, Specialty & Emerging Pharmacy Channel Accounts Background: Specialty pharmacy (SP) is the primary dispensing channel for oncology, rare disease, and REMS ( Risk Evaluation and Mitigation Strategies ) governed products . T he commercial complexity of managing SP partners goes well beyond distribution. SP clinical pharmacists are active participants in patient care; SP data reporting is a core source of pull-through intelligence; and SP REMS compliance is a regulatory obligation with commercial consequences. At the same time, the dispensing landscape is being reshaped by emerging digital pharmacy entrants, each representing a distinct disruptive model that creates both commercial risk and patient access opportunity for the portfolio.…